I migliori medici di Terapia mirata per il cancro ai polmoni in Israele — TOP-4 medici

Il Prof. Merimsky dirige l'Unità di Oncologia dei Tessuti Molli e dell'Osso presso il Sourasky Medical Center, con oltre 25 anni di specializzazione nei trattamenti del cancro al polmone e del sarcoma.

• Formazione in sarcoma presso l'Institut Gustave Roussy a Parigi
• Membro della Facoltà ESMO per i sarcomi dei tessuti molli e dell'osso
• Vicepresidente del Comitato Etico del Sourasky
• Ha pubblicato ricerche sull'immunologia dei tumori e le terapie mirate

Il Dr. Ari Raphael conduce ricerche rivoluzionarie sul cancro ai polmoni presso il Tel Aviv Sourasky Medical Center, concentrandosi sul profilamento genomico e sull'immunoterapia.

• Ricercatore principale per molteplici studi clinici sui trattamenti per il NSCLC
• Esperto in biopsie liquide e profilazione genomica completa
• Membro dell'IASLC e dell'ESMO, organizzazioni chiave nella ricerca sul cancro ai polmoni
• Moderatore del Consiglio Tumori Molecolari della Israeliana Lung Cancer Society
• Destinatario della borsa di ricerca ISCORT e premi per l'insegnamento

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.